3:
Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.
Horton H, Havenar-Daughton C, Lee D, Moore E, Cao J, McNevin J, Andrus T, Zhu H, Rubin A, Zhu T, Celum C, McElrath MJ.
J Virol. 2006 Oct;80(19):9779-88.
PMID: 16973582 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
12:
HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.
Hurwitz JL, Zhan X, Brown SA, Bonsignori M, Stambas J, Lockey TD, Sealy R, Surman S, Freiden P, Jones B, Martin L, Blanchard J, Slobod KS.
Front Biosci. 2008 Jan 1;13:609-20. Review.
PMID: 17981574 [PubMed - indexed for MEDLINE]
Related Articles
17:
Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN, McElrath MJ, Sow PS, Hawes SE, Diallo-Agne H, Stern JE, Li F, Mesher AL, Robinson AD, Gottlieb GS, Huang Y, Kiviat NB.
J Virol. 2007 Sep;81(17):9061-71. Epub 2007 Jun 20.
PMID: 17582003 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
20:
Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques.
Yamamoto H, Kawada M, Tsukamoto T, Takeda A, Igarashi H, Miyazawa M, Naruse T, Yasunami M, Kimura A, Matano T.
J Gen Virol. 2007 Feb;88(Pt 2):652-9.
PMID: 17251584 [PubMed - indexed for MEDLINE]
Related Articles